<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04010097</url>
  </required_header>
  <id_info>
    <org_study_id>87RI19_0009</org_study_id>
    <nct_id>NCT04010097</nct_id>
  </id_info>
  <brief_title>Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort</brief_title>
  <acronym>ChewingHort</acronym>
  <official_title>Evaluation of Sensitivity, Specificity, Positive and Negative Predictive Values of the Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is hypothesized that chewing-gums may be a useful test to unmask jaws intermittent&#xD;
      claudication in order to enhance the diagnosis of Giant Cell Arteritis (GCA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      GCA is the most common vasculitis. The diagnosis easily could be made in patients over 50&#xD;
      years old with headache, inflammatory belt pain, claudication of the jaws, scalp&#xD;
      hyperesthesia, ophthalmological manifestations and an inflammatory syndrome. However, the&#xD;
      clinical pictures could be less suggestive, hence diagnostic difficulties. Some patients have&#xD;
      only isolated inflammatory syndrome. To confirm the diagnosis, sometimes PET CT or temporal&#xD;
      artery biopsy is used, but access to a PET CT is sometimes complex, biopsy of temporal&#xD;
      arteries is only positive in about 70% cases. Early diagnosis is important, however, to avoid&#xD;
      irreversible complications, especially ophthalmological complications. One in six patients&#xD;
      has definitive amaurosis, because of diagnosis delay. The current diagnostic delay is&#xD;
      estimated on average at 9 weeks.&#xD;
&#xD;
      Jaw intermittent claudication probably has a very good positive predictive value and this&#xD;
      clinical sign often carries conviction. Patients with claudication of the jaws also have a&#xD;
      greater visual risk. Kuo reports two observations of patients with claudication of the jaws&#xD;
      revealed by the &quot;chewing gum test&quot; after 2 minutes of chewing. It is therefore proposed to&#xD;
      perform a chewing gum test to assess the sensitivity and specificity of this test, compared&#xD;
      to the interview.&#xD;
&#xD;
      Once the test is done, the study is completed for the patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 30, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the sensitivity and specificity of the chewing gum test in Horton's disease.</measure>
    <time_frame>Day 1</time_frame>
    <description>Determination of:&#xD;
True positive: Sick people correctly identified as sick False positive: Healthy people incorrectly identified as sick True negative: Healthy people correctly identified as healthy False negative: Sick people incorrectly identified as healthy&#xD;
Then wa calculate:&#xD;
the number true positives TP the number of false positives FP the number of true negatives TN the number of false negatives.FN&#xD;
Specificty= TN/(TN+FP) Sensitivity= : TP/(TP+FN) The test is performed twice an hour apart, to verify its reproducibility, before the introduction of corticosteroid therapy, with chewing gums without sugar.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the positive predictive value, the negative predictive value, and the likelihood ratio of the chewing gum test in Horton's disease,</measure>
    <time_frame>Day1</time_frame>
    <description>predictive value= TP/(TP+FP)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Horton Disease</condition>
  <arm_group>
    <arm_group_label>Horton group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The test involves chewing a chewing gum for 4 minutes plus a standard Horton disease diagnostic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N Horton Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The test involves chewing a chewing gum for 4 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>chewing gum</intervention_name>
    <description>The test involves chewing a chewing gum for 4 minutes</description>
    <arm_group_label>Horton group</arm_group_label>
    <arm_group_label>N Horton Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Group 1&#xD;
&#xD;
          -  Any patient suspected of having GCA, that is to say in practice patients in whom a&#xD;
             doctor plans a Doppler ultrasound of temporal arteries or a temporal arteritis biopsy&#xD;
             or an imagery (Angio-CT, Angio-MRI, PET- to scan&#xD;
&#xD;
          -  Patient over 50 years old&#xD;
&#xD;
          -  Patient able to chew a chewing gum for 4 minutes Group 2&#xD;
&#xD;
          -  Patients free from GCA&#xD;
&#xD;
          -  Age matched (Â± 3 years)&#xD;
&#xD;
          -  Patient able to chew a chewing gum for 4 minutes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Group 1&#xD;
&#xD;
          -  Patients known to have a temporomandibular joint pathology&#xD;
&#xD;
          -  Patients who started corticosteroid therapy Group 2&#xD;
&#xD;
          -  Patients known to have temporomandibular joint pathology&#xD;
&#xD;
          -  Patients who started corticosteroid therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CH Avignon</name>
      <address>
        <city>Avignon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH St Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2019</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polymyalgia Rheumatica</mesh_term>
    <mesh_term>Giant Cell Arteritis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

